CRIS · Curis Inc · Metrics
$0.43
-0.04 (-9.03%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 13, 2026
Market Cap
$4.06M
Shares
9.51M
Volume · Nov 20
531.09K
Avg daily vol (3M)
4.27M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
CRIS metrics
70 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$0.43
Market cap
$4.06M
Price action
23 metricsPrice change (1W)
-4.0%
Price change (30D)
+5.5%
Price change (3M)
-73.0%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$27.40
52-week low
$0.38
Change from 52-week high
-98.4%
Change from 52-week low
+13.2%
Annualized volatility
168.6%
Annualized volatility (3M)
179.9%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
40.4
Price vs SMA 50
-38.4%
Price vs SMA 200
—
Avg volume (3M)
4.27M
Relative volume
0.1
Average dollar volume
$4.01M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
9.51M
Valuation
12 metricsP / E (TTM)
0.1
Trailing earnings · reciprocal yield 1,384.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.9×
reciprocal yield 106.2%
P / book
1.6
reciprocal yield 62.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-530.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
1,273.2×
reciprocal yield 0.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-12
Profitability
9 metricsGross margin
—
Operating margin
-60.5%
Trailing 12 months
Net margin
-80.3%
Gross profit (TTM)
—
Operating profit (TTM)
−$10.59M
Net income (TTM)
−$21.54M
Trailing 12 months
Diluted EPS (TTM)
$5.91
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4.31M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+432.9%
Year over year · more shares
Revenue CAGR (3Y)
-2.4%
Revenue CAGR (5Y)
-2.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-844.5%
Return on assets
-114.6%
Debt / equity
0.0
Current ratio
0.4
EBITDA (TTM)
−$10.53M
Free cash flow (TTM)
—
Quick ratio
0.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$5.01M
Latest balance sheet
Cash & equivalents
$5.01M
Total assets
$18.80M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$30.77M
Capital expenditures (TTM)
—
R&D (TTM)
$24.58M
SG&A (TTM)
—
Stock compensation (TTM)
$2.46M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
28
13F filer change QoQ
-11
Institutional ownership
12.2%
Conviction holders (share of 13F filers)
3.6%
Crowding (high-turnover and private-fund holders)
48.5%
Private-fund adviser ownership
40.1%
Active holders' share change QoQ
+46.1%
Holder tenure
8.1
Price vs estimated holder cost
-95.5%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.2%
Short interest
3 metricsShort interest
10.8%
Latest settlement · 1.1 days to cover
Days to cover
1.1d
Short-squeeze score
66 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged
Key facts
CIK
1108205
CUSIP
231269408
13F (30d)
52 filings
29 filers
Visit website
Investor relations